Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (121589) 121589
Newspaper Article (22424) 22424
Newsletter (15112) 15112
Book Chapter (1314) 1314
Magazine Article (903) 903
Dissertation (372) 372
Trade Publication Article (314) 314
Web Resource (205) 205
Conference Proceeding (142) 142
Transcript (127) 127
Book / eBook (113) 113
Publication (38) 38
Reference (38) 38
Book Review (31) 31
Government Document (30) 30
Report (28) 28
Journal / eJournal (10) 10
Streaming Video (8) 8
Paper (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (82880) 82880
science & technology (80688) 80688
life sciences & biomedicine (75830) 75830
hepatitis (57109) 57109
male (48589) 48589
female (47047) 47047
middle aged (37767) 37767
adult (37543) 37543
hepatitis c (33363) 33363
hepatitis c virus (31310) 31310
gastroenterology & hepatology (27255) 27255
infectious diseases (25194) 25194
biological and medical sciences (23870) 23870
medical sciences (22438) 22438
hepatitis b (21822) 21822
health aspects (21712) 21712
aged (19279) 19279
interferon (18405) 18405
infections (17270) 17270
research (17217) 17217
liver (16788) 16788
liver diseases (16579) 16579
antiviral agents - therapeutic use (15801) 15801
risk factors (14197) 14197
viral diseases (14059) 14059
hepatitis b virus (14036) 14036
medical research (13389) 13389
virology (13313) 13313
viral hepatitis (12978) 12978
human viral diseases (12765) 12765
hepatitis c, chronic - drug therapy (12259) 12259
viruses (11982) 11982
care and treatment (11930) 11930
analysis (11006) 11006
liver cancer (10840) 10840
liver cirrhosis (10838) 10838
virus diseases (10611) 10611
adolescent (10438) 10438
hepacivirus - genetics (10416) 10416
treatment outcome (10377) 10377
antiviral agents (10373) 10373
patients (10346) 10346
genotype (10191) 10191
medicine, experimental (10017) 10017
immunology (9475) 9475
animals (9141) 9141
hepatocellular carcinoma (8395) 8395
abridged index medicus (8255) 8255
microbiology (8006) 8006
interferon-alpha - therapeutic use (7851) 7851
medicine (7578) 7578
drug therapy (7556) 7556
hepatitis c, chronic - complications (7334) 7334
young adult (7299) 7299
genetic aspects (7195) 7195
digestive system diseases (7141) 7141
drug therapy, combination (7135) 7135
retrospective studies (7016) 7016
liver - pathology (6999) 6999
research article (6760) 6760
human immunodeficiency virus--hiv (6679) 6679
hepatology (6657) 6657
biological response modifiers (6617) 6617
hepatitis b virus - genetics (6370) 6370
studies (6367) 6367
oncology (6263) 6263
cirrhosis (6062) 6062
prevalence (6050) 6050
clinical trials (6016) 6016
gastroenterology. liver. pancreas. abdomen (6014) 6014
pharmaceutical industry (5947) 5947
chronic disease (5906) 5906
proteins (5895) 5895
antigens (5881) 5881
general & internal medicine (5869) 5869
hepatitis c - complications (5838) 5838
medicine, general & internal (5823) 5823
biopsy (5720) 5720
ribavirin - therapeutic use (5586) 5586
infection (5572) 5572
cancer (5569) 5569
gastroenterology and hepatology (5551) 5551
hepatitis c, chronic - virology (5535) 5535
child (5439) 5439
hiv (5348) 5348
prognosis (5188) 5188
gastroenterology (5180) 5180
ribavirin (5127) 5127
mortality (5118) 5118
recombinant proteins (5100) 5100
epidemiology (5084) 5084
polymerase chain reaction (4992) 4992
development and progression (4983) 4983
genotype & phenotype (4978) 4978
pharmacology & pharmacy (4977) 4977
hepatitis c - epidemiology (4975) 4975
viral load (4967) 4967
fibrosis (4928) 4928
medicine & public health (4812) 4812
hepatitis c - drug therapy (4698) 4698
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
Online Resources - Online (35) 35
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Scarborough Hospital - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
Mt Sinai Hospital - Pathology (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (155710) 155710
French (1778) 1778
Spanish (1339) 1339
Japanese (1168) 1168
German (1100) 1100
Portuguese (997) 997
Chinese (931) 931
Russian (728) 728
Korean (723) 723
Italian (409) 409
Polish (331) 331
Turkish (153) 153
Hungarian (146) 146
Romanian (115) 115
Czech (109) 109
Croatian (62) 62
Dutch (41) 41
Persian (39) 39
Serbian (39) 39
Danish (33) 33
Norwegian (31) 31
Swedish (26) 26
Slovak (18) 18
Ukrainian (16) 16
Hebrew (13) 13
Urdu (8) 8
Bosnian (7) 7
Finnish (5) 5
Bulgarian (4) 4
Indonesian (3) 3
Belarusian (2) 2
Breton (2) 2
Catalan (2) 2
Hindi (2) 2
Icelandic (2) 2
Lithuanian (2) 2
Albanian (1) 1
Azerbaijani (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


41. Full Text Intrahepatic IL-8 producing Foxp3+ CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C
by Langhans, Bettina and Krämer, Benjamin and Louis, Marcell and Nischalke, Hans Dieter and Hüneburg, Robert and Staratschek-Jox, Andrea and Odenthal, Margarethe and Manekeller, Steffen and Schepke, Michael and Kalff, Jörg and Fischer, Hans-Peter and Schultze, Joachim L and Spengler, Ulrich
Journal of hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 2, pp. 229 - 235
Gastroenterology and Hepatology | Hepatic stellate cells | Hepatitis C virus | Regulatory T cells | IL-8 | Fibrogenesis | Regulatory | T cells | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Adaptive Immunity | Biomarkers - metabolism | T-Lymphocytes, Regulatory - metabolism | Up-Regulation | Hepatitis C, Chronic - pathology | Liver - pathology | T-Lymphocytes, Regulatory - classification | Interleukin-8 - biosynthesis | Humans | Middle Aged | Hepatic Stellate Cells - metabolism | Male | Disease Progression | T-Lymphocytes, Regulatory - immunology | Young Adult | Liver - immunology | Hepatic Stellate Cells - immunology | Forkhead Transcription Factors - metabolism | Fibrosis | Hepatitis C, Chronic - immunology | Adult | Female | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
42. Full Text REtrieval And cure of Chronic Hepatitis C (REACH) : Results of micro-elimination in the Utrecht province
by Kracht, Patricia A.M and Arends, Joop E and van Erpecum, Karel J and Thijsen, Steven F.T and Vlaminckx, Bart J.M and Weersink, Annemarie J.L and Wensing, Anne M.J and Deege, Marjolein P.H and Dimmendaal, Marieke and Stadhouders, Paul H.G.M and Friederich, Philip W and Verhagen, Marc A.M.T and Boland, Greet J and Hoepelman, Andy I.M
Liver international, ISSN 1478-3223, 03/2019, Volume 39, Issue 3, pp. 455 - 462
REACH | Research Support, Non-U.S. Gov't | retrieval | Hepatology | hepatitis C virus | micro-elimination | case-finding | direct-acting antivirals | Journal Article | micro‐elimination | direct‐acting antivirals | case‐finding | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Predictive Value of Tests | Disease Eradication | Lost to Follow-Up | Antiviral Agents - therapeutic use | Humans | Middle Aged | Netherlands - epidemiology | Hepatitis C, Chronic - prevention & control | Male | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Mass Screening - methods | Feasibility Studies | Time Factors | Female | Hepatitis C, Chronic - epidemiology | Program Evaluation | Antiviral agents | Medical examination | Medical records | Hepatitis C virus | Hepatitis C | Health aspects | Blood | Health care | Retrieval | RNA viruses | Drug abuse | Therapy | Intravenous administration | Laboratories | Complications | Immunoglobulin G | Chronic infection | Viruses | Infections | Ribonucleic acid--RNA | Patients | Hepatitis | Screening | Diagnostic systems | Interferon | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
43. Full Text Telaprevir for Previously Treated Chronic HCV Infection
by McHutchison, John G and Manns, Michael P and Muir, Andrew J and Terrault, Norah A and Jacobson, Ira M and Afdhal, Nezam H and Heathcote, E. Jenny and Zeuzem, Stefan and Reesink, Hendrik W and Garg, Jyotsna and Bsharat, Mohammad and George, Shelley and Kauffman, Robert S and Adda, Nathalie and M.D, Adrian M. Di Bisceglie and PROVE3 Study Team
The New England journal of medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 14, pp. 1292 - 1303
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Exanthema - chemically induced | Serine Proteinase Inhibitors - adverse effects | Treatment Failure | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Hepatitis C, Chronic - drug therapy | Retreatment | Antiviral Agents - adverse effects | Adolescent | Aged | Viral Load - drug effects | Hemoglobins - analysis | Evaluation | Peginterferon alfa-2a | Patient outcomes | Genetic aspects | Drug therapy, Combination | Hepatitis C | Drug therapy | Hepatitis C virus | Ribavirin | Hepatitis | Genotype & phenotype | Liver diseases | Manuscripts | Committees | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
44. Full Text Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
by Wang, Wenhui and Pan, Qiuwei and Fuhler, Gwenny and Smits, Ron and Peppelenbosch, Maikel
Journal of gastroenterology, ISSN 0944-1174, 04/2017, Volume 52, Issue 4, pp. 419 - 431
Wnt/β-catenin signaling | Hepatitis C virus | Hepatocellular carcinoma | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Surgical Oncology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Neoplasms - virology | Carcinoma, Hepatocellular - physiopathology | Liver Neoplasms - genetics | Liver Cirrhosis - complications | Humans | Hepatitis C, Chronic - physiopathology | Wnt Signaling Pathway - physiology | Carcinoma, Hepatocellular - virology | Hepatitis C, Chronic - complications | Disease Progression | beta Catenin - genetics | Liver Cirrhosis - virology | Wnt Signaling Pathway - genetics | Cell Transformation, Neoplastic | Viral Structural Proteins - physiology | Carcinoma, Hepatocellular - genetics | Liver Neoplasms - physiopathology | Mutation | Index Medicus | β-catenin signaling | Review | Wnt
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
45. Full Text Who to test and how to test for chronic hepatitis C infection – 2016 WHO testing guidance for low- and middle-income countries
by Easterbrook, Philippa J and WHO Guidelines Development Group and WHO Guidelines Dev Grp
Journal of hepatology, ISSN 0168-8278, 2016, Volume 65, Issue 1, pp. S46 - S66
Gastroenterology and Hepatology | Focused testing | Rapid diagnostic tests (RDTs) | Dried blood spots (DBS) | Birth cohort | Hepatitis C | General population testing | Testing | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | World Health Organization | Global Health | Humans | Risk Factors | Male | Hepatitis B, Chronic - diagnosis | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Virology - methods | Developed Countries | Female | Developing Countries | Hepatitis C, Chronic - epidemiology | Virus diseases | HIV testing | Diagnosis | Hepatitis C virus | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
46. Full Text Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”
by Gane, E. J and Agarwal, K
American journal of transplantation, ISSN 1600-6135, 05/2014, Volume 14, Issue 5, pp. 994 - 1002
ledipasvir | sofosbuvir | Boceprevir | ribavirin | telaprevir | low accelerating dose regimen | hepatitis C virus | fibrosis | pegylated interferon | liver transplantation | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Antiviral agents | Viral hepatitis | Infectious diseases | Liver, biliary tract, pancreas, portal circulation, spleen | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Surgery of the digestive system | Antibiotics. Antiinfectious agents. Antiparasitic agents | Hepacivirus - drug effects | Liver Diseases - virology | Postoperative Complications - etiology | Liver Transplantation - adverse effects | Antiviral Agents - therapeutic use | Humans | Hepatitis C, Chronic - prevention & control | Postoperative Complications - prevention & control | Hepatitis C, Chronic - etiology | Hepatitis C, Chronic - drug therapy | Liver Diseases - complications | Liver Diseases - surgery | Postoperative Complications - drug therapy | Virus diseases | Protease inhibitors | Proteases | Liver | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Hepatitis | Infections | Transplants & implants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights